CatalystFDA/Bio

REVOLUTION MEDICINES: STRONG BUY RASONQUE FDA APPROVAL AND ZOLDONRASIB PDAC EXPANSIONS - SEEKINGALPHA

FDA approval and zoldonrasib PDAC expansions drive strong buy thesis.

What changed

FDA approval and zoldonrasib PDAC expansions drive strong buy thesis.

Why it matters

FDA approval and zoldonrasib PDAC expansions drive strong buy thesis. — impact context not separately stored; see What changed.

Sources